Baidu plans to disclose research progress and results on its world model in the near term, according to an exclusive report. World models focus on modeling and predicting physical environments. If ...
XPENG Group Vice President Gu Jie said on October 28 that the solid-state battery for the company’s IRON humanoid robot has entered small-batch mass production and that the robot is currently in the ...
Two ledgers now describe China’s robotics boom. One is the fundraising tape: roughly 124.5 billion yuan in the first eight months of 2026, about double the prio ...
AI-native biopharmaceutical company BioGeometry has completed a Series A+ financing round, bringing its cumulative Series A funding to more than $100 million. The latest round was led by China Life ...
Hong Kong’s IPO market has recorded 117 new listings so far in 2026, raising HK$391.5 billion, according to Wind data as of October 27. The number of IPOs rose 54% from the same period last year, ...
Platforms are answering with automated review systems. Honest advertisers are stuck paying for the cleanup. NextFin News — A skincare pitch built from a cloned face and voice is the kind of abuse ...
Shoppers are testing AI chat for product shortlists while platforms weave assistants into the path to checkout. The technology fits messy retail decisions. Control of the first question—and trust in ...
SK Hynix completed its two-month, 40 trillion won share repurchase program on October 21 on the Korea Exchange. The company bought back 24.07 million shares, or about 3.3 percent of its outstanding ...
Transsion opened weak in Hong Kong after pricing at the floor of its range. Profits rebounded while shipments fell, a mix built on higher prices and older chip stock. Investors are asking whether a ...
Alibaba and JD.com staged rival kickoff events on the same afternoon as Douyin launched its own festival. With growth harder to find, the platforms are competing on timing, brand depth, services and ...
For China’s AI stack, that is a different export story from the ones that usually dominate. Debate has long fixed on whether local models can match Western peers and whether domestic accelerators can ...
TMTPOST — DeliNova Therapeutics, also known as Fengxun Bio, has completed a Pre-A financing round of 100 million yuan. New investors include Bilinxing Capital, Yueyin Medical Fund and Jianggen Capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results